Effect of salmeterol on allergen-induced airway inflammation in mild allergic asthma

Clinical and Experimental Allergy

Volumn 31, Issue 3, 2001, Pages 430-437

  Boulet, L P ^a   Chakir, J ^a   Milot, J ^a   Boutet, M ^a   Laviolette, M ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Airway inflammation; Allergen induced asthma; Long acting 2 adrenergic agonists; SM

Indexed keywords

ALLERGEN; CD4 ANTIGEN; CD45 ANTIGEN; HLA DR ANTIGEN; METHACHOLINE; PLACEBO; SALBUTAMOL; SALMETEROL;

ADULT; ALLERGIC ASTHMA; ARTICLE; BRONCHOSPASM; BRONCHUS BIOPSY; CELL COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATORY CELL; INHALATION TEST; LUNG LAVAGE; MALE; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFLAMMATION;

ADOLESCENT; ADULT; ALBUTEROL; ALLERGENS; ASTHMA; BRONCHODILATOR AGENTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFLAMMATION; MALE; RESPIRATORY SYSTEM; TREATMENT OUTCOME;

EID: 0035725269     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2001.01014.x     Document Type: Article

References (28)

1. Long- versus short-term β2 agonists: Implications for asthma management
2. The influence of inhaled salmeterol on bronchial inflammation. A bronchoalveolar lavage study in patients with bronchial asthma
3. Influence of salmeterol on chronic and allergen-induced airway inflammation in mild allergic asthma: A pilot study
4. The effect of salmeterol on the early- and late-phase reaction to bronchial allergen and postchallenge variation in bronchial reactivity, blood eosinophils, serum eosinophil cationic protein, and serum eosinophil protein X
5. Effects of salmeterol compared with beclomethasone on allergen-induced asthmatic and inflammatory responses
6. β2-agonists as anti-inflammatory therapies in the lung
7. Salmeterol xinafoate: A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease
8. Anti-inflammatory effects of a short-acting and a long-acting beta 2-adrenoceptor agonist in guinea pig skin
9. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma
10. Strandardization of spirometry, 1994 update
11. Prediction of airway responsiveness to allergen from skin sensitivity to allergen and airway responsiveness to histamine
12. Bronchoalveolar lavage cell differential on microscope glass cover
13. Immunochemistry on resin sections: A comparison of resin embedding. Technique for mucosal biopsies
14. Comparison of the effects of salmeterol and salbutamol on clinical activity and eosinophil cationic protein serum levels during the pollen season in atopic asthmatics
15. Repeatability of measures of inflammatory cell number in bronchial biopsies in atopic asthma
16. Allergen-induced airways inflammation in asthma
17. Bronchial and bronchoalveolar inflammation in single early and dual responders after allergen inhalation challenge
18. Effects of salmeterol on eosinophil recruitment to the airway following segmental antigen challenge (SAC) in atopic asthmatics
19. Effect of a single dose of salmeterol on the increase in airway eosinophils induced by allergen challenge in asthmatics subjects
20. The long-acting β2 agonist salmeterol xinafoate: Effects on airway inflammation in asthma
21. Effect of eight weeks of treatment with salmeterol on bronchoalveolar lavage inflammatory indices in asthmatics
22. Long-acting inhaled β2 agonists: Anti-inflammatory effects not evident during treatment of day to day asthma
23. Potential masking effects of salmeterol on airway inflammation in asthma
24. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness
25. Effect of inhaled formoterol and budesonide on exacerbations of asthma
26. Asthma treatment: Inhaled beta-agonists
27. One year treatment with salmeterol compared with beclomethasone in children with asthma